The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Cortical remyelination: A new target for repair therapies in multiple sclerosis
Open accessAbstract
OBJECTIVE: Generation and differentiation of new oligodendrocytes in demyelinated white matter is the best described repair process in the adult human brain. However, remyelinating capacity falters with age in patients with multiple sclerosis (MS). Because demyelination of cerebral cortex is extensive in brains from MS patients, we investigated the capacity of cortical lesions to remyelinate and directly compared the extent of remyelination in lesions that involve cerebral cortex and adjacent subcortical white matter. METHODS: Postmortem brain tissue from 22 patients with MS (age 27-77 years) and 6 subjects without brain disease were analyzed. Regions of cerebral cortex with reduced myelin were examined for remyelination, oligodendrocyte progenitor cells, reactive astrocytes, and molecules that inhibit remyelination. RESULTS: New oligodendrocytes that were actively forming myelin sheaths were identified in 30 of 42 remyelinated subpial cortical lesions, including lesions from 3 patients in their 70s. Oligodendrocyte progenitor cells were not decreased in demyelinated or remyelinated cortices when compared to adjacent normal-appearing cortex or controls. In demyelinated lesions involving cortex and adjacent white matter, the cortex showed greater remyelination, more actively remyelinating oligodendrocytes, and fewer reactive astrocytes. Astrocytes in the white matter, but not in cortical portions of these lesions, significantly upregulate CD44, hyaluronan, and versican, molecules that form complexes that inhibit oligodendrocyte maturation and remyelination. INTERPRETATION: Endogenous remyelination of the cerebral cortex occurs in individuals with MS regardless of disease duration or chronological age of the patient. Cortical remyelination should be considered as a primary outcome measure in future clinical trials testing remyelination therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Although OPCs represent an available pool to replace lost oligodendrocytes and myelin, replacement is limited, particularly in cortical lesions (Chang et al. 2012).”
From Depletion of Microglia Increases Cortical Oligodendrocyte Density During Remyelination (2026) · cites this paper as Chang et al. 2012
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous studies in human post-mortem tissue and experimental models suggested that remyelination after a demyelinating insult is more efficient in the cerebral cortex compared to the white matter.”
From BCAS1-positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis (2025) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In patients with multiple sclerosis, remyelination has been observed in both white and grey matter and found to be more efficient in the cortex.”
From BCAS1-positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis (2025) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“Studies in human tissue and experimental models suggest that numerical and functional differences in oligodendrocyte lineage cells, as well as e.g. the phenotype of reactive astrogliosis, including a lower expression of CD44, versican and hyaluronan in the cortex, may play a role.15”
From BCAS1-positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis (2025) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Noseworthy, J. H., Lucchinetti, C. F., Rodriguez, M., & Weinshenker, B. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431307 · Cited by 3,016
CD44: From adhesion molecules to signalling regulators
Ponta, H., Sherman, L. S., & Herrlich, P. A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1004 · Cited by 2,458
Cortical demyelination and diffuse white matter injury in multiple sclerosis
Kutzelnigg, A., Lucchinetti, C. F., Stadelmann, C., Brück, W., Rauschka, H., Bergmann, M., Schmidbauer, M., Parisi, J. E., & Lassmann, H. (2005) · Brain · doi:10.1093/brain/awh641 · Cited by 1,836
Remyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544
Peterson, J. W., Bö, L., Mörk, S., Chang, A., & Trapp, B. D. (2001) · Annals of Neurology · doi:10.1002/ana.1123 · Cited by 1,403
Self-citationPremyelinating Oligodendrocytes in Chronic Lesions of Multiple Sclerosis
Chang, A., Tourtellotte, W. W., Rudick, R., & Trapp, B. D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa010994 · Cited by 991
Self-citationKuhlmann, T., Miron, V., Cuo, Q., Wegner, C., Antel, J., & Bruck, W. (2008) · Brain · doi:10.1093/brain/awn096 · Cited by 864
Remyelination is extensive in a subset of multiple sclerosis patients
Patrikios, P., Stadelmann, C., Kutzelnigg, A., Rauschka, H., Schmidbauer, M., Laursen, H., Sorensen, P. S., Bruck, W., Lucchinetti, C., & Lassmann, H. (2006) · Brain · doi:10.1093/brain/awl217 · Cited by 807
Cortical lesions in multiple sclerosis
Kidd, D., Barkhof, F., McConnell, R., Algra, P. R., Allen, I. V., & Revesz, T. (1999) · Brain · doi:10.1093/brain/122.1.17 · Cited by 766
Subpial Demyelination in the Cerebral Cortex of Multiple Sclerosis Patients
Bø, L., Vedeler, C. A., Nyland, H. I., Trapp, B. D., & Mørk, S. J. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.7.723 · Cited by 757
Self-citation
Cited by
Sorted by citations
Pathological mechanisms in progressive multiple sclerosis
Mahad, D., Trapp, B. D., & Lassmann, H. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70256-x · Cited by 1,198
Self-citationMyelin in the Central Nervous System: Structure, Function, and Pathology
Stadelmann, C., Timmler, S., Barrantes‐Freer, A., & Simons, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00031.2018 · Cited by 799
Multiple sclerosis progression: time for a new mechanism-driven framework
Kuhlmann, T., Moccia, M., Coetzee, T., Cohen, J. A., Correale, J., Graves, J., Marrie, R. A., Montalban, X., Yong, V. W., Thompson, A. J., et al. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00289-7 · Cited by 667
Self-citationNeuronal vulnerability and multilineage diversity in multiple sclerosis
Schirmer, L., Velmeshev, D., Holmqvist, S., Kaufmann, M., Werneburg, S., Jung, D., Vistnes, S., Stockley, J. H., Young, A., Steindel, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1404-z · Cited by 638
Pathophysiology of the brain extracellular matrix: a new target for remyelination
Lau, L. W., Cua, R., Keough, M. B., Haylock-Jacobs, S., & Yong, V. W. (2013) · Nature reviews. Neuroscience · doi:10.1038/nrn3550 · Cited by 549
Self-citationRemyelination in multiple sclerosis: From basic science to clinical translation
Lubetzki, C., Zalc, B., Williams, A., Stadelmann, C., & Stankoff, B. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30140-x · Cited by 350
Multiple sclerosis—a quiet revolution
Ransohoff, R. M., Hafler, D. A., & Lucchinetti, C. F. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.14 · Cited by 342
Remyelination therapies: a new direction and challenge in multiple sclerosis
Plemel, J. R., Liu, W., & Yong, V. W. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.115 · Cited by 293
Self-citationImmunosenescence of microglia and macrophages: impact on the ageing central nervous system
Rawji, K. S., Mishra, M. K., Michaels, N. J., Rivest, S., Stys, P. K., & Yong, V. W. (2016) · Brain · doi:10.1093/brain/awv395 · Cited by 252
Self-citationIron in multiple sclerosis: roles in neurodegeneration and repair
Stephenson, E. L., Nathoo, N., Mahjoub, Y., Dunn, J. F., & Yong, V. W. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.118 · Cited by 253
Self-citationRelapsing and progressive forms of multiple sclerosis
Dutta, R., & Trapp, B. D. (2014) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000094 · Cited by 252
Self-citationZirngibl, M., Assinck, P., Sizov, A., Caprariello, A. V., & Plemel, J. R. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00538-8 · Cited by 233
Myelin damage and repair in pathologic CNS: challenges and prospects
Alizadeh, A., Dyck, S. M., & Karimi‐Abdolrezaee, S. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00035 · Cited by 246
Cognitive Impairment in Multiple Sclerosis: Clinical, Radiologic and Pathologic Insights
DeLuca, G. C., Yates, R. L., Beale, H., & Morrow, S. A. (2014) · Brain Pathology · doi:10.1111/bpa.12220 · Cited by 228
Cerebral small vessel disease genomics and its implications across the lifespan
Sargurupremraj, M., Suzuki, H., Jian, X., Sarnowski, C., Evans, T. E., Bis, J. C., Eiriksdottir, G., Sakaue, S., Terzikhan, N., Habes, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19111-2 · Cited by 220
Dyck, S. M., & Karimi‐Abdolrezaee, S. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.04.006 · Cited by 197
The extracellular matrix as modifier of neuroinflammation and remyelination in multiple sclerosis
Ghorbani, S., & Yong, V. W. (2021) · Brain · doi:10.1093/brain/awab059 · Cited by 191
Self-citationCell-based therapeutic strategies for multiple sclerosis
Scolding, N. J., Pasquini, M. C., Reingold, S. C., Cohen, J. A., Sclerosis:, I. C. O. C.-B. T. F. M., Atkins, H. L., Banwell, B., Bar‐Or, A., Bebo, B. F., Bowen, J. D., et al. (2017) · Brain · doi:10.1093/brain/awx154 · Cited by 177
Mechanisms of Neurodegeneration and Axonal Dysfunction in Progressive Multiple Sclerosis
Correale, J., Marrodan, M., & Ysrraelit, M. C. (2019) · Biomedicines · doi:10.3390/biomedicines7010014 · Cited by 167
Promoting remyelination in multiple sclerosis
Cunniffe, N. G., & Coles, A. J. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09421-x · Cited by 172
Burnside, E. R., & Bradbury, E. J. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12114 · Cited by 161
Advanced MRI and staging of multiple sclerosis lesions
Absinta, M., Sati, P., & Reich, D. S. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.59 · Cited by 161
The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis
Mallucci, G., Peruzzotti‐Jametti, L., Bernstock, J. D., & Pluchino, S. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.02.003 · Cited by 153
Inflammation in multiple sclerosis: consequences for remyelination and disease progression
Klotz, L., Antel, J. P., & Kuhlmann, T. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00801-6 · Cited by 125
Remyelination alters the pattern of myelin in the cerebral cortex
Orthmann-Murphy, J., Call, C. L., Molina-Castro, G. C., Hsieh, Y. C., Rasband, M. N., Calabresi, P. A., & Bergles, D. E. (2020) · eLife · doi:10.7554/elife.56621 · Cited by 111
The Molecular Basis for Remyelination Failure in Multiple Sclerosis
Gruchot, J., Weyers, V., Göttle, P., Förster, M., Hartung, H., Küry, P., & Kremer, D. (2019) · Cells · doi:10.3390/cells8080825 · Cited by 117
Brown, J. W. L., Cunniffe, N. G., Prados, F., Kanber, B., Jones, J., Needham, E., Georgieva, Z. G., Rog, D. J., Pearson, O. R., Overell, J. R., et al. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00179-4 · Cited by 101
Call, C. L., & Bergles, D. E. (2021) · Nature Communications · doi:10.1038/s41467-021-25035-2 · Cited by 95
Genetics of common cerebral small vessel disease
Bordes, C., Sargurupremraj, M., Mishra, A., & Debette, S. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-021-00592-8 · Cited by 108
Baxi, E. G., DeBruin, J., Jin, J., Strasburger, H. J., Smith, M. D., Orthmann‐Murphy, J. L., Schott, J. T., Fairchild, A. N., Bergles, D. E., & Calabresi, P. A. (2017) · Glia · doi:10.1002/glia.23229 · Cited by 97
The Afferent Visual Pathway: Designing a Structural-Functional Paradigm of Multiple Sclerosis
Costello, F. (2013) · ISRN Neurology · doi:10.1155/2013/134858 · Cited by 93
Hyaluronan in immune dysregulation and autoimmune diseases
Nagy, N., Kuipers, H. F., Marshall, P. L., Wang, E., Kaber, G., & Bollyky, P. L. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.03.022 · Cited by 94
Pushing Forward: Remyelination as the New Frontier in CNS Diseases
Kremer, D., Göttle, P., Hartung, H., & Küry, P. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.02.004 · Cited by 92
Zurawski, J. D., Lassmann, H., & Bakshi, R. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.4237 · Cited by 88
Progress in understanding the pathophysiology of multiple sclerosis
Zéphir, H. (2018) · Revue Neurologique · doi:10.1016/j.neurol.2018.03.006 · Cited by 97
Jafarzadeh, A., & Nemati, M. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.09.003 · Cited by 84
Hyaluronan Synthesis, Catabolism, and Signaling in Neurodegenerative Diseases
Sherman, L. S., Matsumoto, S. G., Su, W., Srivastava, T., & Back, S. A. (2015) · International Journal of Cell Biology · doi:10.1155/2015/368584 · Cited by 84
Toward Precision Phenotyping of Multiple Sclerosis
Pitt, D., Lo, C. H., Gauthier, S. A., Hickman, R. A., Longbrake, E. E., Airas, L. M., Mao‐Draayer, Y., Riley, C., Jager, P. L. D., Wesley, S., et al. (2022) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200025 · Cited by 87
Self-citationCortical remyelination is heterogeneous in multiple sclerosis
Strijbis, E. M. M., Kooi, E.-J., van der Valk, P., & Geurts, J. J. G. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlx023 · Cited by 82
Luo, F., Tran, A. P., Li, X., Sanapala, C., Lang, B. T., Silver, J., & Yang, Y. (2018) · Nature Communications · doi:10.1038/s41467-018-06505-6 · Cited by 84
Inhibitors of myelination: ECM changes, CSPGs and PTPs
Harlow, D. E., & Macklin, W. B. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.10.017 · Cited by 79
Pu, A., Stephenson, E. L., & Yong, V. W. (2018) · Glia · doi:10.1002/glia.23333 · Cited by 82
Self-citationDiversity and Function of Glial Cell Types in Multiple Sclerosis
Schirmer, L., Schafer, D. P., Bartels, T., Rowitch, D. H., & Calabresi, P. A. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.01.005 · Cited by 78
Promoting remyelination in multiple sclerosis: Current drugs and future prospects
Kremer, D., Küry, P., & Dutta, R. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458514566419 · Cited by 81
Self-citationThe Role of Vitamin D in Neuroprotection in Multiple Sclerosis: An Update
Sangha, A., Quon, M., Pfeffer, G., & Orton, S. M. (2023) · Nutrients · doi:10.3390/nu15132978 · Cited by 81
Oligodendrocyte precursor cells as a therapeutic target for demyelinating diseases
Skaper, S. D. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.03.013 · Cited by 73
Feliú, A., Moreno‐Martet, M., Mecha, M., Carrillo-Salinas, F. J., de Lago, E., Fernández‐Ruíz, J., & Guaza, C. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13159 · Cited by 72
Feliú, A., Río, I. B., Carrillo-Salinas, F. J., Hernández‐Torres, G., Mestre, L., Puente, N., Ortega‐Gutiérrez, S., López-Rodríguez, M. L., Grandes, P., Mecha, M., et al. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.2900-16.2017 · Cited by 71
Psenicka, M. W., Smith, B. C., Tinkey, R. A., & Williams, J. L. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.654284 · Cited by 73
Impact of aging on treatment considerations for multiple sclerosis patients
Macaron, G., Larochelle, C., Arbour, N., Galmard, M., Girard, M., Prat, A., & Duquette, P. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1197212 · Cited by 71
Lindner, M., Thümmler, K., Arthur, A. T., Brunner, S. P., Elliott, C., McElroy, D., Mohan, H., Williams, A., Edgar, J. M., Schuh, C., et al. (2015) · Brain · doi:10.1093/brain/awv102 · Cited by 67
Androgen Therapy in Neurodegenerative Diseases
Bianchi, V. E., Rizzi, L., Bresciani, E., Omeljaniuk, R. J., & Torsello, A. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa120 · Cited by 69
A mouse model for testing remyelinating therapies
Bai, C. B., Sun, H. S., Roholt, A., Benson, E. K., Edberg, D. D., Medicetty, S., Dutta, R., Kidd, G. J., Macklin, W. B., & Trapp, B. D. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.06.033 · Cited by 68
Self-citationMyelin replacement triggered by single-cell demyelination in mouse cortex
Snaidero, N., Schifferer, M., Mezydlo, A., Zalc, B., Kerschensteiner, M., & Misgeld, T. (2020) · Nature Communications · doi:10.1038/s41467-020-18632-0 · Cited by 63
Klotho protein in neurodegenerative disorders
Torbus, M., Bartman, W., & Adamczyk-Sowa, M. H. (2018) · Neurological Sciences · doi:10.1007/s10072-018-3496-x · Cited by 69
Remyelination by surviving oligodendrocytes is inefficient in the inflamed mammalian cortex
Mezydlo, A., Treiber, N., Ullrich Gavilanes, E. M., Eichenseer, K., Ancău, M., Wens, A., Ares Carral, C., Schifferer, M., Snaidero, N., Misgeld, T., et al. (2023) · Neuron · doi:10.1016/j.neuron.2023.03.031 · Cited by 63
Niu, J., Yu, G., Wang, X., Xia, W., Wang, Y., Hoi, K. K., Mei, F., Xiao, L., Chan, J. R., & Fancy, S. P. J. (2021) · Neuron · doi:10.1016/j.neuron.2021.07.018 · Cited by 61
Markoullis, K., Sargiannidou, I., Schiza, N., Roncaroli, F., Reynolds, R., & Kleopa, K. A. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000106 · Cited by 63
Lentferink, D. H., Jongsma, J. M., Werkman, I. L., & Baron, W. (2018) · Scientific Reports · doi:10.1038/s41598-018-19934-6 · Cited by 63
Stephenson, E. L., & Yong, V. W. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.04.010 · Cited by 63
Self-citationThe Anti-Aging Protein Klotho Enhances Remyelination Following Cuprizone-Induced Demyelination
Zeldich, E., Chen, C.-D., Avila, R. L., Medicetty, S., & Abraham, C. R. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0598-2 · Cited by 59
The mTOR Signaling Pathway in Multiple Sclerosis; from Animal Models to Human Data
Vakrakou, A. G., Alexaki, A., Brinia, M.-E., Anagnostouli, M. C., Stefanis, L., & Stathopoulos, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158077 · Cited by 65
Ghorbani, S., Jelinek, E., Jain, R. W., Buehner, B. J., Li, C., Lozinski, B. M., Sarkar, S., Kaushik, D. K., Dong, Y., Wight, T. N., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30032-0 · Cited by 57
Self-citationTargeting human oligodendrocyte progenitors for myelin repair
Dietz, K. C., Polanco, J. J., Pol, S. U., & Sim, F. J. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.03.017 · Cited by 56
Khodanovich, M. Y., Pishchelko, A. O., Glazacheva, V., Pan, E. S., Евгеньевич, А. А., Светлик, М. В., Tyumentseva, Y., Anan’ina, T. V., & Yarnykh, V. L. (2019) · Cells · doi:10.3390/cells8101204 · Cited by 53
Disease-modifying treatments for progressive multiple sclerosis
Comı, G. (2013) · Multiple Sclerosis Journal · doi:10.1177/1352458513502572 · Cited by 52
Moore, S. M., Khalaj, A. J., Yoon, J., Patel, R., Hannsun, G., Yoo, T. S., Manda, S. V., Martinez‐Torres, L., Hayardeny, L., & Tiwari-Woodruff, S. K. (2013) · Brain and Behavior · doi:10.1002/brb3.174 · Cited by 53
Diagnosis and treatment of progressive multiple sclerosis: A position paper
Pozzilli, C., Pugliatti, M., Vermersch, P., Grigoriadis, N., Alkhawajah, M. M., Airas, L. M., & Oreja‐Guevara, C. (2022) · European Journal of Neurology · doi:10.1111/ene.15593 · Cited by 61
Mohan, H., Friese, A. I., Albrecht, S., Krumbholz, M., Elliott, C., Arthur, A. T., Menon, R., Farina, C., Junker, A., Stadelmann, C., et al. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0168-9 · Cited by 50
Remyelination in multiple sclerosis: Cellular mechanisms and novel therapeutic approaches
Olsen, J. A., & Akirav, E. M. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23493 · Cited by 51
Connexin 43 deletion in astrocytes promotes CNS remyelination by modulating local inflammation
Li, T., Niu, J., Yu, G., Ezan, P., Yi, C., Wang, X., Koulakoff, A., Gao, X., Chen, X., Sáez, J. C., et al. (2019) · Glia · doi:10.1002/glia.23770 · Cited by 49
Cacciaguerra, L., Redenbaugh, V., Chen, J. J.-W., Morris, P. P., Sechi, E., Syc‐Mazurek, S. B., Lopez-Chiriboga, A. S., Tillema, J., Rocca, M. A., Filippi, M., et al. (2023) · Neurology · doi:10.1212/wnl.0000000000207478 · Cited by 46
Tissue remodeling in periplaque regions of multiple sclerosis spinal cord lesions
Lieury, A., Chanal, M., Androdias, G., Reynolds, R., Cavagna, S., Giraudon, P., Confavreux, C., & Nataf, S. (2014) · Glia · doi:10.1002/glia.22705 · Cited by 45
Beyond focal cortical lesions in MS
Louapre, C., Govindarajan, S. T., Giannì, C., Langkammer, C., Sloane, J. A., Kinkel, R. P., & Mainero, C. (2015) · Neurology · doi:10.1212/wnl.0000000000002106 · Cited by 45
Chronic oligodendrocyte injury in central nervous system pathologies
Molina-González, I., Miron, V. E., & Antel, J. P. (2022) · Communications Biology · doi:10.1038/s42003-022-04248-1 · Cited by 48
Rodriguez, E. G., Wegner, C., Kreutzfeldt, M., Neid, K., Thal, D. R., Jürgens, T., Brück, W., Stadelmann, C., & Merkler, D. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1260-8 · Cited by 44
Myelin Repair: From Animal Models to Humans
Cayre, M., Falque, M., Mercier, O., Magalon, K., & Durbec, P. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.604865 · Cited by 44
Wang, P., Gorter, R. P., de Jonge, J. C., Nazmuddin, M., Zhao, C., Amor, S., Hoekstra, D., & Baron, W. (2018) · Glia · doi:10.1002/glia.23328 · Cited by 40
The influence of HLA‐DRB1*15 on motor cortical pathology in multiple sclerosis
Yates, R. L., Esiri, M. M., Palace, J. A., Mittal, A., & DeLuca, G. C. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12165 · Cited by 41
Sherafat, A., Pfeiffer, F., & Nishiyama, A. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.721376 · Cited by 40
Thornton, M. A., Futia, G. L., Stockton, M. E., Budoff, S. A., Ramirez, A. N., Ozbay, B. N., Tzang, O., Kilborn, K., Poleg-Polsky, A., Restrepo, D., et al. (2024) · Nature Neuroscience · doi:10.1038/s41593-024-01613-7 · Cited by 44
Stephenson, E. L., Zhang, P., Ghorbani, S., Wang, A., Gu, J., Keough, M. B., Rawji, K. S., Silva, C., Yong, V. W., & Ling, C. (2019) · ACS Central Science · doi:10.1021/acscentsci.9b00327 · Cited by 40
Self-citationCross-regional homeostatic and reactive glial signatures in multiple sclerosis
Trobisch, T., Zulji, A., Stevens, N. A., Schwarz, S., Wischnewski, S., Öztürk, M., Perales-Patón, J., Haeussler, M., Saez-Rodriguez, J., Velmeshev, D., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02497-2 · Cited by 40
Oligodendroglial Maturation Is Dependent on Intracellular Protein Shuttling
Göttle, P., Sabo, J. K., Heinen, A., Venables, G., Torres, K. J., Tzekova, N., Parras, C. M., Kremer, D., Hartung, H., Cate, H. S., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.1423-14.2015 · Cited by 37
Remyelination After Cuprizone-Induced Demyelination Is Accelerated in Juvenile Mice
Pfeifenbring, S., Nessler, S., Wegner, C., Stadelmann, C., & Brück, W. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000214 · Cited by 39
Barbierato, M., Facci, L., Marinelli, C., Zusso, M., Argentini, C., Skaper, S. D., & Giusti, P. (2015) · Scientific Reports · doi:10.1038/srep16676 · Cited by 36
Cerina, M., Narayanan, V., Göbel, K., Bittner, S., Ruck, T., Meuth, P., Herrmann, A. M., Stangel, M., Gudi, V., Skripuletz, T., et al. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.08.014 · Cited by 36
The substrate of increased cortical FA in MS: A 7T post-mortem MRI and histopathology study
Jonkman, L. E., Klaver, R., Fleysher, L., Inglese, M., & Geurts, J. J. G. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516635290 · Cited by 33
Youssef, A. E. H., Dief, A. E., El Azhary, N. M., Abdelmonsif, D. A., & El-fetiany, O. S. (2019) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-018-00660-6 · Cited by 35
Lazzarotto, A., Hamzaoui, M., Tonietto, M., Dubessy, A.-L., Khalil, M., Pirpamer, L., Ropele, S., Enzinger, C., Battaglini, M., Stromillo, M. L., et al. (2024) · Brain · doi:10.1093/brain/awae024 · Cited by 33
Cellular senescence and failure of myelin repair in multiple sclerosis
Koutsoudaki, P. N., Papadopoulos, D., Passias, P.-G., Koutsoudaki, P., & Gorgoulis, V. G. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111366 · Cited by 33
Verden, D. R., & Macklin, W. B. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23923 · Cited by 33
Macroglial diversity: white and grey areas and relevance to remyelination
Werkman, I. L., Lentferink, D. H., & Baron, W. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03586-9 · Cited by 33
Casamassa, A., Rocca, C. L., Sokolow, S., Herchuelz, A., Matarese, G., Annunziato, L., & Boscia, F. (2016) · Glia · doi:10.1002/glia.22985 · Cited by 32
Lee, J. Y., & Petratos, S. (2013) · The Neuroscientist · doi:10.1177/1073858413477207 · Cited by 31
Kuboyama, K., Tanga, N., Suzuki, R., Fujikawa, A., & Noda, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189164 · Cited by 32
Tripathi, A. K., Volsko, C. M., Datta, U., Regev, K., & Dutta, R. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.750 · Cited by 27
Self-citationAccelerated repair of demyelinated CNS lesions in the absence of non‐muscle myosin IIB
Rusielewicz, T., Nam, J., Damanakis, E., John, G. R., Raine, C. S., & Melendez‐Vasquez, C. V. (2014) · Glia · doi:10.1002/glia.22627 · Cited by 24
Krämer, J., Brück, W., Zipp, F., Cerina, M., Groppa, S., & Meuth, S. G. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101663 · Cited by 27
Sigma-1 receptor agonists as potential protective therapies in multiple sclerosis
Lisak, R. P., Nedelkoska, L., & Benjamins, J. A. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577188 · Cited by 25
Metadata
- Authors
- Chang, A., Staugaitis, S. M., Dutta, R., Batt, C. E., Easley, K. E., Chomyk, A. M., Yong, V. W., Fox, R. J., Kidd, G. J., & Trapp, B. D.
- Affiliations
- Cleveland Clinic (US)
- University of Calgary (CA)
- Corresponding author
- Trapp, Bruce D.
- ORCID
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2012-10-17
- Volume
- 72
- Issue
- 6
- Pages
- 918-926
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- PMC
- PMC3535551
- OpenAlex
- W2061522969
- Cited by
- 216
- References
- 42
- Citations by year
- 2026: 6 · 2025: 15 · 2024: 10 · 2023: 19 · 2022: 22 · 2021: 16 · 2020: 18 · 2019: 23 · 2018: 16 · 2017: 11 · 2016: 16 · 2015: 16 · 2014: 13 · 2013: 13 · 2012: 2
- FWCI
- 10.17
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Multiple Sclerosis Society
- Cleveland Clinic
- National Institutes of Health (UL1TR000439)
- University of California, Davis
- National Institute of Neurological Disorders and Stroke (NS38867, P50NS038667)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- multiple sclerosis, demyelination, oligodendrocyte precursor cells, reactive astrocytes, CD44, hyaluronic acid, versican, oligodendrocyte maturation, white matter lesions, remyelination therapy
- MeSH terms
- Chondroitin Sulfate Proteoglycan 4, Adult, Aged, Antigens, Cerebral Cortex, Demyelinating Diseases, Female, Glial Fibrillary Acidic Protein, Humans, Male, Middle Aged, Multiple Sclerosis, Myelin Sheath, Nerve Fibers, Myelinated, Oligodendroglia, Postmortem Changes, Proteoglycans, Regeneration, RNA, Messenger, Hyaluronan Receptors, Myelin Proteolipid Protein, Adaptor Proteins, Signal Transducing, Adult Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
